EU Affirms Trade Deal Protects Pharmaceutical Exports From US Tariffs
(MENAFN- Kuwait News Agency (KUNA))
BRUSSELS, Sept 26 (KUNA) -- The European Commission reaffirmed that the trade agreement between the European Union (EU) and the US guarantees protection for European pharmaceutical exports from any tariffs exceeding 15 percent, following US President Donald Trump's announcement of 100 percent tariffs imposed on drugs.
European Commission Deputy Chief Spokesperson Olof Gill told reporters, "this clear all-inclusive 15 percent tariff ceiling for EU exports represents an insurance policy that no higher tariffs will emerge for European economic operators."
EU and US will continue engaging towards implementing the joint statement commitments, while exploring further areas for tariff exemptions, he added.
Gill highlighted the July agreement, which explicitly states tariff rates on pharmaceuticals, semiconductors and lumber must not exceed 15 percent.
Earlier today, Trump announced a 100-percent tariff on imported drugs, trucks, and furniture, warning all branded or patented pharmaceutical products would face tariffs unless companies establish drug manufacturing plants within the US. (end)
arn
European Commission Deputy Chief Spokesperson Olof Gill told reporters, "this clear all-inclusive 15 percent tariff ceiling for EU exports represents an insurance policy that no higher tariffs will emerge for European economic operators."
EU and US will continue engaging towards implementing the joint statement commitments, while exploring further areas for tariff exemptions, he added.
Gill highlighted the July agreement, which explicitly states tariff rates on pharmaceuticals, semiconductors and lumber must not exceed 15 percent.
Earlier today, Trump announced a 100-percent tariff on imported drugs, trucks, and furniture, warning all branded or patented pharmaceutical products would face tariffs unless companies establish drug manufacturing plants within the US. (end)
arn
.jpg)
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Kintsu Launches Shype On Hyperliquid
- Barunson, Studio Behind Parasite, To Launch Nplug IP Remixing Platform On Story And Bring Flagship IP Onchain
- Moonbirds And Azuki IP Coming To Verse8 As AI-Native Game Platform Integrates With Story
- Leverage Shares Launches First 3X Single-Stock Etps On HOOD, HIMS, UNH And Others
- Alchemy Markets Launches Tradingview Integration For Direct Chart-Based Trading
- Dexari Unveils $1M Cash Prize Trading Competition
Comments
No comment